1986
DOI: 10.1021/jm00160a004
|View full text |Cite
|
Sign up to set email alerts
|

Functional cholesteryl binding agents: synthesis, characterization, and evaluation of antibody binding to modified phospholipid vesicles

Abstract: A series of functionalized cholesteryl derivatives were synthesized. The various lipophilic protein modification agents were analyzed for their protein binding ability. The binding of human IgG, labeled with 125I, to modified phospholipid vesicles was ascertained. Two agents performed well. These were cholest-5-en-3 beta-yl 5-carboxypentyl ether succinimido ester and cholest-5-en-3 beta-yl 6-carboxyhexyl ether succinimido ester.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1987
1987
2011
2011

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(2 citation statements)
references
References 3 publications
(7 reference statements)
0
2
0
Order By: Relevance
“…In this way the antibody was covalently bound to the outside of the vesicle. 45 In this study the N-hydroxysuccinimide esters were shown to be better than cholesterol derivatives with isothiocyanate or maleimide reactive end groups. Only the N-hydroxysuccinimide esters gave protein binding which was significantly higher than background nonspecific binding.…”
Section: Uses Of the Hydroxysuccinimide Derivatives 6 Andmentioning
confidence: 75%
“…In this way the antibody was covalently bound to the outside of the vesicle. 45 In this study the N-hydroxysuccinimide esters were shown to be better than cholesterol derivatives with isothiocyanate or maleimide reactive end groups. Only the N-hydroxysuccinimide esters gave protein binding which was significantly higher than background nonspecific binding.…”
Section: Uses Of the Hydroxysuccinimide Derivatives 6 Andmentioning
confidence: 75%
“…Thus at pH 8e9, lipid vesicles functionalized with an N-hydroxy succinimido ester react with human IgG, binding the antibody to the outside of the vesicle. 8 Using tethers bearing a maleimide head-group 9e11 it is possible to bind proteins that contain free eSH residues. Maleimide containing tethers have been used to create 'immunoliposomes' using an antibody that targets the epidermal growth factor receptor that is over expressed in brain tumor cells.…”
Section: Introductionmentioning
confidence: 99%